Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Overview

This article presents a protocol for genetically engineering THP-1 cells, a model for human macrophages, to study their resistance to HIV infection. The focus is on elucidating the role of the enzyme HT-1 in degrading viral genome components.

Key Study Components

Area of Science

• Neuroscience
• Cell Biology
• Infectious Diseases

Background

• THP-1 cells are widely used as a surrogate for human macrophages.
• Understanding macrophage resistance to HIV is crucial for AIDS research.
• HT-1 enzyme has multiple activities affecting viral replication.
• CRISPR-Cas9 technology allows for precise genetic modifications.

Purpose of Study

• To develop a protocol for efficient genetic engineering of THP-1 cells.
• To investigate the mechanisms of HIV resistance in macrophages.
• To produce reproducible phenotypic data for further research.

Methods Used

• CRISPR-Cas9-based engineering of THP-1 cells.
• Single-cell clone isolation techniques.
• Phenotypic analysis of engineered cells.
• Investigation of enzyme activities related to HIV resistance.

Main Results

• Successful genetic modification of THP-1 cells using CRISPR-Cas9.
• Isolation of single-cell clones for detailed study.
• Insights into the role of HT-1 in HIV resistance.
• Establishment of a reproducible protocol for future research.

Conclusions

• The developed protocol enhances the study of macrophage biology.
• Understanding HT-1's functions could lead to new therapeutic strategies.
• THP-1 cells remain a valuable model for HIV research.

Frequently Asked Questions